pmid	doi	title	Hugo_Symbol
34653294	10.1111/cas.15164	C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations.	BLNK
33570628	10.1182/bloodadvances.2020001665	Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.	BLNK
33416167	10.3892/or.2020.7888	Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cells.	BLNK
33020271	10.1073/pnas.2007946117	Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.	BLNK
32585766	10.1002/1878-0261.12753	Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma.	BLNK
32420699	10.1002/cam4.3136	Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.	BLNK
31882553	10.21873/cgp.20169	BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach.	BLNK
30890517	10.12122/j.issn.1673-4254.2019.02.20	[Structure and function of B-cell linker and its role in the development of B cell-related diseases].	BLNK
30872780	10.1038/s41375-019-0442-8	Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.	BLNK
30402490	10.1155/2018/6728128	Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.	BLNK
29931583	10.1007/s10637-018-0623-8	Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.	BLNK
28972016	10.1182/blood-2017-06-743252	Philadelphia chromosome-like acute lymphoblastic leukemia.	BLNK
28791394	10.3892/mmr.2017.7158	Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.	BLNK
28476192	10.1016/j.arcmed.2016.12.005	Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.	BLNK
28369050	10.1038/ni.3716	Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.	BLNK
27016671	10.1016/j.molimm.2016.03.007	PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.	BLNK
26703467	10.1074/jbc.M115.637835	B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.	BLNK
26522721	10.1038/onc.2015.385	ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway.	BLNK
26354285	10.1002/hon.2251	Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.	BLNK
25391967	10.1007/s11060-014-1655-3	Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.	BLNK
25080849	10.1111/ejh.12427	B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.	BLNK
24240734	10.1007/s00401-013-1202-x	Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.	BLNK
24169826	10.1182/blood-2012-12-473090	The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.	BLNK
23066158	10.4049/jimmunol.1201440	Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice.	BLNK
22956576	10.4049/jimmunol.1201267	Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.	BLNK
22880054	10.1371/journal.pone.0042610	Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.	BLNK
22262777	10.1182/blood-2011-04-351965	CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.	BLNK
20876806	10.1158/0008-5472.CAN-10-1438	Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.	BLNK
19855081	10.1182/blood-2009-02-204362	BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.	BLNK
19850008	10.1016/j.bbrc.2009.10.070	Phosphatidylinositol-3-kinase-dependent phosphorylation of SLP-76 by the lymphoma-associated ITK-SYK fusion-protein.	BLNK
19758698	10.1016/j.leukres.2009.08.030	Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma.	BLNK
19150402	10.1016/j.cellsig.2008.12.006	SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux.	BLNK
19047679	10.1182/blood-2008-07-166355	BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.	BLNK
18566961	10.1002/path.2384	The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.	BLNK
18426802	10.1074/jbc.M708459200	Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling.	BLNK
18172310	10.1158/0008-5472.CAN-07-2778	PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.	BLNK
18006696	10.1182/blood-2007-07-100115	SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.	BLNK
17717600	10.1172/JCI30842	B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.	BLNK
16888096	10.1182/blood-2006-03-013821	Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.	BLNK
16636677	10.1038/sj.onc.1209520	SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.	BLNK
16568084	10.1038/sj.onc.1209510	The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.	BLNK
15744341	10.1038/sj.leu.2403702	Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.	BLNK
15231650	10.1158/0008-5472.CAN-03-3885	High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.	BLNK
15029213	10.1038/sj.leu.2403349	Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia.	BLNK
14984504	10.1111/j.1365-2141.2004.04802.x	Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.	BLNK
12881301	10.1182/blood-2003-05-1487	Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease.	BLNK
12761551	10.1038/nature01608	Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.	BLNK
12436112	10.1038/ni862	The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.	BLNK
10498607		Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.	BLNK
11489945	10.1084/jem.194.3.255	Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.	BLNK
9341187	10.1074/jbc.272.43.27362	Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation.	BLNK
